Skip to main content

Tacita Capital Inc

Position in NVS — Novartis AG

CIK 1846287 TORONTO, A6

Position in NVS

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$138,697
-$44,603 QoQ
Shares Held
885
-26.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,346
of 1,603 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Tacita Capital Inc holds $1,098,276 across 7 Drug Manufacturers - General names. NVS ranks #2 (12.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NVS
Novartis AG
This page
885 $138,697

All Filings in NVS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $138,697 885
2026-03-31 $183,300 1,200
2025-12-31 $165,444 1,200
2025-09-30 $153,888 1,200
2025-06-30 $145,212 1,200
2025-03-31 $133,776 1,200
2024-12-31 $116,772 1,200
2024-09-30 $138,024 1,200
2024-06-30 $127,752 1,200
2024-03-31 $116,076 1,200
2023-12-31 $121,164 1,200
2023-09-30 $122,232 1,200
2023-06-30 $121,092 1,200
2023-03-31 $110,400 1,200
2022-12-31 $108,864 1,200
2022-09-30 $91,212 1,200
2022-06-30 $101,436 1,200
2022-03-31 $105,300 1,200
2021-12-31 $104,964 1,200
2021-09-30 $98,136 1,200
2021-06-30 $109,488 1,200
2021-03-31 $102,576 1,200
2020-12-31 $113,316 1,200